A speedy recovery: Amphetamines and other therapeutics that might impact the recovery from brain injury

Current Opinion in Anaesthesiology

Volumn 24, Issue 2, 2011, Pages 144-153

  Harbeck Seu, Anja ^a   Brunk, Irene ^a   Platz, Thomas ^b   Vajkoczy, Peter ^c   Endres, Matthias ^a,c   Spies, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Ernst Moritz Arndt Universität ^*  (Germany)

Author keywords

Amphetamine; brain injury; ketamine; neuroprotection; rehabilitation; stroke

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE; CARBIDOPA; DEXAMPHETAMINE; KETAMINE; LEVODOPA; METHOHEXITAL; METHYLPHENIDATE; MIDAZOLAM; OPIATE; PLACEBO;

APOPTOSIS; ARTICLE; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; COGNITION; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; HYPOTHESIS; INFLAMMATION; INTRACRANIAL HYPERTENSION; LOW DRUG DOSE; NEUROMONITORING; NEUROPROTECTION; NONHUMAN; PATIENT TRANSPORT; PERFUSION PRESSURE; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT;

AMPHETAMINES; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CRANIOCEREBRAL TRAUMA; EMERGENCY MEDICAL SERVICES; HUMANS; INTRACRANIAL HYPERTENSION; PATIENT TRANSFER; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; STROKE;

EID: 79952964020     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328344587f     Document Type: Article

References (63)

1. Nudo RJ. Plasticity. NeuroRx 2006;3:420-427. (Pubitemid 44443014)
2. Mackay J, Mensah GA. The atlas of heart disease and stroke, World Health Organization, Geneva. 2004, [cited from 30.09.2010] Available from: http://www.who.int/cardiovascular-disease/resources/atlas/en/.
3. American Heart Association. Heart disease and stroke statistics-2004 update. Stroke. (ICD/9 430-438) (ICD/10 160-169). American Heart Association, Dallas TX, 13-16, 2003.
4. Jennett B. Epidemiology of head injury. J Neurol Neurosurg Psychiatry 1996;60:362-369. (Pubitemid 26118740)
5. Rickels E, editor. Schädel-Hirnverletzung. Epidemiologie und Versorgung. Ergebnisse einer prospektiven Studie, Zuckschwerdt-Verlag; 2006.
6. Goldstein LB. Amphetamine trials and tribulations. Stroke 2009;40:133-135.
7. Hardman JG, Limbird LE, Molinoff PB, et al. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw Hill; 1996.
8. Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36(Database issue): D901-6. PMID: 18048412, [cited 2010 Sep. 30] Available from: http://www.drugbank.ca/drugs/DB01576. (Pubitemid 351149842)
9. Creese I. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 1975;83:419-436.
10. Boyeson MG. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 1990;35:497-501. (Pubitemid 20115729)
11. Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast 1993;4:175-192. (Pubitemid 24126343)
12. Boyeson MG. Sparing of motor function after cortical injury. A new perspective on underlying mechanisms. Arch Neurol 1994;51:405-414. (Pubitemid 24110524)
13. Robertson SD, Matthies HJ, Galli A. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 2009;39:78-80.
14. Unwin H, Walker-Batson D. No side-effects after low-dose amphetamine administration on stroke rehabilitation. Stroke 2000;31:1788-1789. (Pubitemid 30437542)
15. Bongiovanni B, Ferri A, Brusco A, et al. Adverse effects of 2, 4-dichlorophenoxyacetic acid on rat cerebellar granule cell cultures were attenuated by amphetamine. Neurotox Res 2010 [Epub ahead of print].
16. Krasnova IN, Hodges AB, Ladenheim B, et al. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice. Neurosci Res 2009;65:160-165.
17. Papadopoulos CM, Tsai SY, Guillen V, et al. Motor recovery and axonal plasticity with short-term amphetamine after stroke. Stroke 2009;40:294-302.
18. Auriat AM, Colbourne F. Influence of amphetamine on recovery after intracerebral hemorrhage in rats. Behav Brain Res 2008;186:222-229. (Pubitemid 350122754)
19. Griesbach GS, Hovda DA, Gomez-Pinilla, Sutton RL. Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience 2008;154:530-540.
20. Alaverdashvili M, Lim DH, Whishaw IQ. No improvement by amphetamine on learned nonuse, attempts, success or movement in skilled reaching by the rat after motor cortex stroke. Eur J Neurosci 2007;25:3442-3452. (Pubitemid 46872778)
21. Barbay S, Zoubina EV, Dancause N, et al. A single injection of D-amphetamine facilitates improvements in motor training following a focal cortical infarct in squirrel monkeys. Neurorehabil Neural Repair 2006;20:455-458. (Pubitemid 44690626)
22. Ramic M, Emerick AJ, Bollnow MR, et al. Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. Brain Res 2006;1111:176-186. (Pubitemid 44331174)
23. Rasmussen RS, Overgaard K, Hildebrandt-Eriksen ES, Boysen G. D-amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model. Acta Neurol Scand 2006;113:189-198.
24. Adkins DL, Jones TA. D-amphetamine enhances skilled reaching after ischemic cortical lesions in rats. Neurosci Lett 2005;380:214-218. (Pubitemid 40616082)
25. Chudasama Y, Nathwani F, Robbins TW. D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions. Behav Brain Res 2005;158:97-107. (Pubitemid 40174715)
26. Gilmour G, Iversen SD, O'Neill MJ, et al. Amphetamine promotes taskdependent recovery following focal cortical ischaemic lesions in the rat. Behav Brain Res 2005;165:98-109. (Pubitemid 41476209)
27. Brown AW, Bjelke B, Fuxe K. Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model. Exp Neurol 2004;190:102-108. (Pubitemid 39335710)
28. Sprigg N, Willmot MR, Gray LJ, et al. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333). J Hum Hypertens 2007;21:616-624. (Pubitemid 47162724)
29. Sprigg N, Bath P M W Bath. Speeding stroke recovery? A systematic review of amphetamine after stroke. J Neurol Sci 2009;285:3-9.
30. Barbay S, Nudo RJ. The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal. Neuro Rehabil 2009;25:5-17. This review highlights the difficulties of translating preclinical study settings to clinical study settings in humans.
31. Lokk J, Salman Roghani R, Delbari A. Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke: a randomized, double-blind, placebo-controlled trial. Acta Neurol Scand 2010 [Epub ahead of print].
32. Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci 2007;25:143-150. (Pubitemid 47290442)
33. Sonde L, Lökk J. Effects of amphetamine and/or l-dopa and physiotherapy after stroke-a blinded randomized study. Acta Neurol Scand 2007;115:55-59. (Pubitemid 44915499)
34. Gladstone DJ, Danells CJ, Armesto A, et al. Subacute therapy with amphetamíne and rehabilitation for stroke study investigators. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2006;37:179-185. (Pubitemid 43732068)
35. Platz T, Kim IH, Engel U, et al. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial. Restor Neurol Neurosci 2005;23(5-6): 271-280. (Pubitemid 41746161)
36. Martinsson L, Eksborg S, Wahlgren NG. Intensive early physiotherapy combined with dexamphetamine treatment in severe stroke: a randomized, controlled pilot study. Cerebrovasc Dis 2003;16:338-345. (Pubitemid 37140422)
37. Treig T, Werner C, Sachse M, Hesse S. No benefit from d-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 2003;17:590-599. (Pubitemid 37063046)
38. Sonde L, Nordström M, Nilsson CG, et al. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis 2001;12:253-257. (Pubitemid 32973958)
39. Walker-Batson D, Curtis S, Natarajan R, et al. A double-blind, placebocontrolled study of the use of amphetamine in the treatment of aphasia. Stroke 2001;32:2093-2098.
40. Czlonkowska A, Lesniak M. Pharmacotherapy in stroke rehabilitation. Expert Opin Pharmacother 2009;10:1249-1259.
41. Tardy J, Pariente J, Leger A, et al. Methylphenidate modulates cerebral poststroke reorganization. Neuroimage 2006;33:913-922. (Pubitemid 44584756)
42. Fugl-Meyer AR, JääsköL, Leyman I, et al. The poststroke hemiplegic patient. 1a method for evaluation of physical performance. Scand J Rehabil Med 1975;7:13-31.
43. Gladstone DJ, Danells CJ, Black SE. The Fugl-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair 2002;16:232-240. (Pubitemid 34984898)
44. Bütefisch CM, Davis BC, Sawaki L, et al. Modulation of use-dependent plasticity by d-amphetamine. Ann Neurol 2002;51:59-68. (Pubitemid 34027978)
45. Sawaki L, Cohen LG, Classen J, et al. Enhancement of use-dependent plasticity by d-amphetamine. Neurology 2002;59:1262-1264. (Pubitemid 35192404)
46. Hesse S. Recovery of gait and other motor functions after stroke: novel physical and pharmacological treatment strategies. Restor Neurol Neurosci 2004;22(3-5): 359-369. (Pubitemid 39468291)
47. Martin J, Heymann A, Bäsell K, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. GMS Ger Med Sci 2010;8: Doc02. This German guideline comprises among others therapeutic recommendations concerning brain injury with special regard to increased intracerebral pressure.
48. Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr 2009;4:40-46.
49. Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth 2010;24:131-142. This review summarizes current knowledge about the neuroprotective effects of ketamine.
50. Bartoc C, Frumento RJ, Jalbout M, et al. A randomized, double-blind, placebocontrolled study assessing the anti-inflammatory effects of ketamine in cardiac surgical patients. J Cardiothorac Vasc Anesth 2006;20:217-222.
51. Sakai T, Ichiyama T, Whitten CW, et al. Ketamine suppresses endotoxininduced NF kappaB expression. Can J Anaesth 2000;47:1019-1024.
52. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-683. (Pubitemid 26130197)
53. Hudetz JA, Iqbal Z, Gandhi SD, et al. Ketamine attenuates postoperative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand 2009;53:864-872.
54. Hudetz JA, Patterson KM, Iqbal Z, et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2009;23:651-657.
55. Brain Trauma Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma 2007;24 Suppl 1: S45-S54.
56. Diringer NM, Reaven NL, Funk SE, Uman GC. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 2004;32:1489-1495. (Pubitemid 38925177)
57. Andrews PJ, Citerio G, Longhi L, et al., Neuro-Intensive Care and Emergency Medicine (NICEM) Section of the European Society of Intensive Care Medicine. NICEMconsensus on neurological monitoring in acute neurological disease. Intensive Care Med 2008;34:1362-1370.
58. Piek J. Guidelines for the prehospital care of patients with severe head injuries. Working Group for Neurosurgical Intensive Care of the European Society of Intensive Care Medicine. Intensive Care Med 1998;24:1221-1225.
59. Ferdinande P. Recommendations for intra-hospital transport of theseverelyhead injuredpatient. Working Groupon Neurosurgical Intensive Care of the European Society of Intensive Care Medicine. Intensive CareMed 1999;25:1441-1443.
60. Brunk I, Sanchis-Segura C, Blex C, et al. Amphetamine regulates NR2B expression in Go2alpha knockout mice and thereby sustains behavioural sensitization. J Neurochem 2010;115:234-246.
61. Brunk I, Blex C, Sanchis-Segura C, et al. Deletion of Go2alpha abolishes cocaine-induced behavioural sensitization by disturbing the striatal dopamine system. FASEB J 2008;22:3736-3746.
62. Kapur S, Seeman P. NMDA receptor antagonist's ketamine and PCP have direct effects on the dopamine D (2) and serotonin 5-HT (2) receptorsimplications for models of schizophrenia. Mol Psychiatry 2002;7:837-844.
63. Martinsson L, Hardemark H, Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2007; CD002090. This article is the latest Cochrane database systematic review concerning the beneficial effects of amphetamines.